{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to mskcc.org Home
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand Courses
  • Gift Certificates
  • Visiting Us
  • About
  • Contact
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Sign in (MSK Employees Only)
Sign in or Create an Account (Non-MSK Employee)
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy


3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy Banner

  • Overview
  • Register
  • Faculty
  • Brochure
  • Abstract
  • Support
Add to Calendar 3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy 4/28/2023 9:00:00 AM 4/29/2023 1:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?P=0&EID=36154 Description: This international symposium will bring together experts and thought leaders in the fields of HCT, cellular therapies, and related subspecialties. Speakers will discuss mechanisms of toxicities, symptom burden, and late effects after these therapies and best practices to prevent and treat them. Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Friday, April 28, 2023, 9:00 AM - Saturday, April 29, 2023, 1:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Bone Marrow Transplant, Cellular Therapeutics, Critical Care, Hematology, Immunotherapy, Infectious Diseases, Internal Medicine, Medical Oncology, Pulmonary Medicine, Solid Tumor Oncology

Overview

This 3rd international Symposium will bring together a diverse group of experts and thought leaders in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss current advances in the field, mechanisms of toxicities, symptom burden, and late effects after HCT and cellular therapies along with best practices to prevent and treat these complications.

This unique 2-day program will be comprised of sessions dedicated to a wide range of pre-clinical, translational, and clinical topics, including cellular therapies as a model of accelerated aging, CAR T cell-related toxicities, infectious complications, decision science, the role of the gut microbiome in toxicities, debates on how to diagnose and treat difficult complications such as transplant-associated thrombotic microangiopathy, and several keynote lectures from world experts.

Our symposium will help facilitate networking and multidisciplinary research collaborations. Additionally, attendees are invited to a special luncheon (space limited) and a networking/poster reception.

>> Who Should Attend

The target audience for this Symposium includes physicians, advanced practice providers (physician assistants and nurse practitioners), and nurses who treat or refer patients for hematopoietic cell transplantation or immune effector cell therapies (i.e., CAR T cells; tumor infiltrating lymphocytes, or T cell receptor therapy).

In-person or Virtual Registration Available: This Symposium will be available in-person at Memorial Sloan Kettering's Zuckerman Research Center in New York or virtually via Zoom. In-person attendees have the option to register to attend the special luncheon session as well as the networking/poster reception.

>> Special Luncheon Session (In-person Only)

Available to in-person attendees only, the focus of this optional luncheon session is on Improving Outcomes with Active Acute Leukemia Undergoing Transplant. Due to space, the luncheon is only available to 50 attendees and selection must be made during course registration. We do recommend early registration in order to secure your spot. Luncheon confirmation will be sent prior to the start of the Symposium.

>> Networking and Poster Reception (In-person Only)

In-person attendees are also invited to attend the networking reception, which will include an exciting poster session. This event will be held in the lobby of Zuckerman Research Center and RSVP is required. If you are interested in joining the reception, please be sure to select this as an option in your registration. Hors d'oeuvre and refreshments will be served.

>> Call for Abstracts (Submission Deadline: April 7)

We are pleased to invite the submission of abstracts for this Symposium. Abstracts will be selected on the basis of their scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted.

The top five awarded abstracts will receive complimentary registration to the symposium. Abstracts can be submitted through the 'Abstract' tab above. Please do not register prior to receiving confirmation of acceptance.

  • The submission deadline for abstracts is April 7, 2023.
  • Notification of acceptance will be sent April 14, 2023.
Please note that a complete faculty list and agenda will be available online soon. Stay tuned with course announcements: #MSKToxTCT

Objectives
  1. Identify the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
  2. Discuss the best practices in the prevention and treatment of toxicities and symptom burden after HCT and cellular therapy.
  3. Collaborate with a multidisciplinary group of colleagues to discuss, brainstorm, and plan future quality improvement and research efforts to reduce toxicities, improve the patient experience, and decrease non-relapse mortality.

Registration

Registration Fees (In-person or Virtual)

  • Physicians (MDs, PhDs, PharmDs, and DOs)
    • Early Rate: $400
    • General Rate: $450
  • Advanced Practice Providers
    • Early Rate: $300
    • General Rate: $350
  • Residents, Fellows, Nurses, Data Managers, and Other Healthcare Providers
    • Early Rate: $225
    • General Rate: $275
  • MSK Employees
    • Complimentary
  • Industry Professionals*
    • Early Rate: n/a
    • General Rate: $775

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

  • EARLY RATE: Register by 11:59 pm EST on March 17, 2023 to receive a $50 off your total registration. Enter the promotion code TXEARLY23 during registration to take advantage of the early rate discount.
  • A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this Symposium. If you are a member of one of these groups, contact [email protected] for details.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

In-person Registration

Course registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the Networking and Poster Reception on Friday evening. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.

Virtual Registration

The virtual option for this program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, will be sent to virtual registrants via email prior to the start of the Symposium.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Keywords: AMA PRA Category 1Call for AbstractsIn-person or VirtualNetworking Reception



MSK Symposium Director


Sergio A. Giralt, MD
Deputy Division Head; Attending, Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Chief Medical Officer, MSK Direct
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  

 

MSK Symposium Co-Director


Michael Scordo, MD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  


Symposium Planning Committee

Rafael F. Duarte, MD, PhD, FRCP
Head, Department of Hematology and Transplantation Programme, 
Hospital Universitario Puerta de Hierro Majadahonda;
Profesor Asociado de Hematología - Universidad Autónoma de Madrid
Madrid, Spain

Shahinaz Gadalla, MD, PhD
Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics 
National Cancer Institute, NIH
Bethesda, MD 

Vincent T. Ho, MD 
Clinical Director, Adult Hematopoeitic Stem Cell Transplantation 
Dana-Farber Cancer Institute
Boston, MA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota 
Minneapolis, MN

Robert R. Jenq, MD
Associate Professor, Deputy Chair, Genomic Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Karthik Nath, MBBS, PhD
Assistant Attending , Cellular Therapy Service
Memorial Sloan Kettering Cancer Center 
New York, NY 

Armin Rashidi, MD, PhD
Associate Professor
Fred Hutchinson Cancer Center 
Seattle, WA

Gabriela Rondon, MD
Professor, Department of Stem Cell Transplantation - Research, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Melody Smith, MD, MS
Assistant Professor, Medicine 
Division of Blood and Marrow Transplantation and Cellular Therapy 
Stanford Medicine 
Stanford, CA

Anthony D. Sung, MD
Associate Professor of Medicine
Duke Blood Cancer Center 
Durham, NC

Anna Sureda, MD, PhD
Head of Department, Clinical Hematology Department
Institut Català d’Oncologia - Hospitalet
Barcelona, Spain

Sumithira Vasu, MBBS, MD
Associate Professor
OSU James Cancer Hospital 
Columbus, OH

 

John Reid Wingard, MD 
Deputy Director, University of Florida Health Cancer Center
Director, Bone Marrow Transplant Program 
UF Health Cancer Center 
Gainesville, FL

William A. Wood, MD, MPH
Professor of Medicine
University of North Carolina School of Medicine 
Chapel Hill, NC

Gregory A. Yanik, MD
Professor, Pediatric Hematology/Oncology, Pediatrics, and Internal Medicine,
Medical Director, Bone Marrow, Medical School
University of Michigan Medicine 
Ann Arbor, MI

 

MSK Symposium Faculty 

Genovefa Papanicolaou, MD
Attending Physician
Infectious Disease Service 
Professor, Weill Cornell Medicine

Jonathan Peled, MD, PhD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

Jacob Glass, MD, PhD
Assistant Attending
Leukemia Service

Gunjan L. Shah, MD, MS
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

 

Invited Symposium Faculty 

Lawrence A. David, MD, PhD  
Associate Professor, Molecular Genetics and Microbiology 
Duke University Schoool of Medicine
Durham, NC 

Mette Hazenberg, MD, PhD
Cinical Hematologist; Physician-Scientist; Group Leader, Immunologist
Amsterdam UMC and Sanquin Research
Amsterdam, The Netherlands 

Josh Hill, MD
Associate Professor, Vaccine and Infectious Disease and Clinical Research 
Fred Hutchinson Cancer Center
Seattle, WA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota
Minneapolis, MN 

Jonathan Huggins, MD
Assistant Professor, Medicine and Infectious Diseases 
Duke University Schoool of Medicine
Durham, NC

Nandita Khera, MD, MPH
Professor, Medicine
Mayo Clinic Alix School of Medicine 
Phoenix, AZ

Marcela Maus, MD
Associate Professor, Medicine
Harvard Medical School 
Massachusetts General Hospital Cancer Center
Boston, MA

Laura Niedernhofer, MD, PhD
Director, Institute on the Biology of Aging and Metabolism
The University of Minnesota
Minneapolis, MN

Amanda Olson, MD
Associate Professor
Department of Stem Cell Tranplantation and Cellular Therapy
MD Anderson Cancer Center
Houston, TX

Samir Parekh, MD
Professor of Medicine
Mount Sinai
New York, NY

Pavan V. Reddy, MD
Director, Duncan Cancer Center 
Senior Associate Dean, Cancer Programs 
Baylor College of Medicine
Houston, TX 

Daniel Richardson, MD
Assistant Professor
The University of North Carolina
School of Medicine
Chapel Hill, NC 

Nirali N. Shah, MD, MHSc
Head, Hematologic Malignancies Section
National Cancer Institute, NIH 
Bethesda, MD

Noha Sharafeldin, MD, MSc, PhD
Assistant Professor
Division of Hematology & Oncology 
Institute for Cancer Outcomes and Survivorship 
The University of Alabama at Birmingham
Birmingham, AL

Robert Soiffer, MD
Chief, Division of Hematologic Malignancies 
Dana-Farber Cancer Institute
Boston, MA

Marion Subklewe, MD
Attending Physician
Head of Immunotherapy in Hematology
LMU University Hospital Munich
Munich, Germany



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Michael Scordo, MD
MSK
Activity Co-Director, Faculty
Consulting Fee-Omeros Corporation|Grant or research support-Omeros Corporation|Grant or research support-Amgen, Inc.|Consulting Fee-Kite - A Gilead Company (Relationship has ended)|Grant or research support-Angiocrine Bioscience, Inc.|Consulting Fee-Angiocrine Bioscience, Inc. (Relationship has ended)
Sergio Giralt, MD
MSK
Activity Director, Faculty
Consulting Fee-AMGEN|Grant or research support-Bristol-Myers Squibb|Consulting Fee-GlaxoSmithKline|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Johnson and Johnson|Consulting Fee-jazz|Consulting Fee-sanofi|Consulting Fee-KITE|Consulting Fee-Novartis AG
Karthik D Nath, MBBS
MSK
Conflict of Interest Peer Reviewer, Faculty
Nothing to disclose
Armin Rashidi, MD, PhD
Fred Hutchinson Cancer Center
Conflict of Interest Peer Reviewer, Faculty, Moderator
Nothing to disclose
Lawrence David, MD, PhD
Duke University Schoool of Medicine
Faculty
Nothing to disclose
Jacob Glass, MD, PhD
MSK
Faculty
Nothing to disclose
Mette D. Hazenberg, MD, PhD
Amsterdam UMC and Sanquin Research
Netherlands
Faculty
Nothing to disclose
Josh Hill, MD
Fred Hutchinson Cancer Center
Faculty
Consulting Fee-Octapharma AG (Relationship has ended)|Consulting Fee-OptumHealth (Relationship has ended)|Consulting Fee-Karius|Consulting Fee-Pfizer, Inc.|Consulting Fee-Covance/CSL Behring|Consulting Fee-Up-to-Date|Consulting Fee-Century Therapeutics|Consulting Fee-Takeda Pharmaceuticals, Inc.|Consulting Fee-Eversana|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-Allovir|Consulting Fee-SymBio|Consulting Fee-SentiBio|Advisor-Moderna|Advisor-Allovir|Grant or research support-Allovir|Grant or research support-Gilead (Relationship has ended)|Advisor-Karius|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Merck and Company, Inc.|Grant or research support-Oxford Immunotec|Grant or research support-Deverra
Jonathan Huggins, MD, MD, MSCE
Duke University Schoool of Medicine
Faculty
Nothing to disclose
Nandita Khera, MD, MPH
Mayo Clinic
Faculty
Consulting Fee-Incyte Corporation (Relationship has ended)
Marcela Maus, MD, PhD
Massachusetts General Hospital Cancer Center
Faculty
Consulting Fee-Adaptimmune, Agenus, Allogene, Arcellx, Astellas, AstraZeneca, Atara, Bayer, BMS, Cabaletta Bio (SAB), Cellectis (SAB), CRISPR therapeutics, EMD Serono, Genocea, In8bio (SAB), Intellia, GSK, Kite Pharma, Micromedicine/BendBio, Neximmune, Novartis, Oncternal, Sanofi, Synthekine, TCR2 (SAB), Tmunity, and Werewolf, WindMIL (SAB)|Royalties or Patent Beneficiary-Marcela V. Maus, MD., PhD, is an inventor on patents related to adoptive cell therapies, held by Massachusetts General Hospital and University of Pennsylvania (some licensed to Novartis). MVM holds equity in TCR2, Century Therapeutics, Genocea, Oncternal, and Neximmune, and has served as a consultant for multiple companies involved in cell therapies. (Relationship has ended)|Grant or research support-Kite Pharma, Servier, Novartis (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Century Therapeutics, Genocea, Oncternal, TCR2, 2Seventy Bio (Relationship has ended)|Board of Directors Member-2SeventyBio (Relationship has ended)
Laura J Niedernhofer, MD, PhD, Director
The University of Minnesota
Faculty
Grant or research support-Pfizer, Inc.|Grant or research support-Merck and Company, Inc.
Amanda Olson, MD
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Genovefa (Zenia) Papanicolaou, MD
MSK
Faculty
Honoraria-shionogi|Honoraria-advarra|Advisor-Cidara|Honoraria-Merck and Company, Inc.|Advisor-Behring|Consulting Fee-AlloVIr|Consulting Fee-Octapharma|Consulting Fee-Symbio|Independent Contractor (included contracted research)-Merck and Company, Inc. (Relationship has ended)|Advisor-Takeda Pharmaceuticals, Inc.|Advisor-Astellas
Samir Parekh, MD
Mount Sinai
Faculty
Nothing to disclose
Jonathan (Tsoni) U Peled, MD, PhD
MSK
Faculty
Other: Research Funding, Intellectual Property Fees, Travel Reimbursement-Seres Therapeutics|Consulting Fee-DaVolterra|Advisor-Postbiotics+ Research LLC
Pavan Reddy, MD
Baylor College of Medicine
Faculty
Nothing to disclose
Daniel Richardson, MD
The University of North Carolina | School of Medicine
Faculty
Nothing to disclose
Gunjan Shah, MD, MS
MSK
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Amgen|Grant or research support-Beyond Spring|Grant or research support-Bristol-Myers Squibb|Review Panel Member-Arcellx
Nirali Shah, MD, MHSc
National Cancer Institute, NIH
Faculty
Nothing to disclose
Noha Sharafeldin, MD, MSc, PhD
The University of Alabama at Birmingham
Faculty
Nothing to disclose
Robert Soiffer, MD
Dana-Farber Cancer Institute
Faculty
Consulting Fee-Astella|Consulting Fee-Vor Biopharma|Consulting Fee-Smart Immune|Consulting Fee-Neovii|Consulting Fee-Bluesphere Bio|Consulting Fee-Cugene|Consulting Fee-Jasper|Advisor-Celgene|Board of Directors Member-NMPD Be The Match
Marion Sabine Subklewe, MD, internist with focus on hematology
LMU University Hospital Munich
Germany
Faculty
Grant or research support-Amgen, BMS/Celgene, Gilead, Janssen, Miltenyi, Morphosys, Novartis, Roche, Seagen, Takeda|Speakers Bureau-Amgen, AstraZeneca, BMS/Celgene, Gilead, GSK, Miltenyi, Novartis, Pfizer, Roche, Takeda|Advisor-LMU Klinikum Med III
Rafael Duarte, MD
Hospital Universitario Puerta de Hierro Majadahonda
Faculty, Moderator
Honoraria-Gilead|Honoraria-Merck and Company, Inc.|Honoraria-Takeda Pharmaceuticals, Inc.
Shahinaz Gadalla, MD, PhD
National Cancer Institute, NIH
Faculty, Moderator
Nothing to disclose
Shernan G Holtan, MD
The University of Minnesota
Faculty, Moderator
Grant or research support-Incyte Corporation|Grant or research support-Vitrac Therapeutics|Review Panel Member-CSL Behring
Robert Jenq, MD
The University of Texas MD Anderson Cancer Center
Faculty, Moderator
Advisor-Seres|Advisor-Kaleido (Relationship has ended)|Advisor-LISCure (Relationship has ended)|Advisor-MaaT Pharma|Advisor-Prolacta
Melody Smith, MD, PhD
Stanford Medicine
Faculty, Moderator
Advisor-Bristol-Myers Squibb (Relationship has ended)
Anthony Sung, MD
Duke Blood Cancer Center
Faculty, Moderator
Consulting Fee-Targazyme|Grant or research support-Clasado|Grant or research support-DSM/iHealth|Grant or research support-Merck and Company, Inc.
Anna Sureda, MD
Institut Català d'Oncologia - Hospitalet
Faculty, Moderator
Consulting Fee-Takeda Pharmaceuticals, Inc.|Advisor-Sanofi-Aventis|Honoraria|Honoraria-Sanofi-Aventis|Honoraria-Gilead|Consulting Fee-Gilead|Grant or research support-Takeda Pharmaceuticals, Inc.|Consulting Fee-Johnson and Johnson|Advisor-Novartis AG|Honoraria-Novartis AG|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Bristol-Myers Squibb|Consulting Fee-Bristol-Myers Squibb
Sumithira Vasu, MD
OSU James Cancer Hospital
Faculty, Moderator
Advisor-Omeros Inc|Grant or research support-Sanofi
John Reid R. Wingard, MD
UF Health Cancer Center
Faculty, Moderator
Consulting Fee-Celgene|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Takeda Pharmaceuticals, Inc.|Other: Consulting Fee-Cidara|Consulting Fee-Orca|Consulting Fee-Ansun
William Wood, MD, MPH
The University of North Carolina | School of Medicine
Faculty, Moderator
Advisor-Koneksa Health|Paid consultant-Teladoc|Advisor-Quantum Health|Grant or research support-Genentech, Inc.|Grant or research support-Pfizer, Inc. (Relationship has ended)
Gregory Yanik, MD
The Univesity of Michigan Medicine
Faculty, Moderator
Grant or research support-Jazz Pharmaceuticals (Relationship has ended)|Honoraria-Sanofi-Aventis (Relationship has ended)
Vincent Ho, MD
Dana-Farber Cancer Institute
Faculty, Planner
Consulting Fee-Omeros|Advisor-Alexion|Grant or research support-Jazz|Grant or research support-CareDx|Review Panel Member-Allovir|Advisor-Orca-Bio
Gabriela Rondon, MD
The University of Texas MD Anderson Cancer Center
Faculty, Planner
Consulting Fee-Omeros Pharma Corporation

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

Actinium Pharmaceuticals, Inc.
Angiocrine Bioscience, Inc.
Novartis

Abstract Submission

The 3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy invites the submission of abstract posters in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted. Abstracts will be selected to be displayed during the symposium. 

Abstract submission deadline: Friday, April 7, 2023
Notification of acceptance will be provided by April 14, 2023.

Please do NOT register before submitting an abstract. Top 5 accepted authors will receive complimentary registration for this symposium. After you have been accepted, you will receive detailed instructions from MSK CME upon abstract approval.



Submit your Abstract

View Submitted Abstracts

MSK CME LINKS

Live Courses
On Demand Courses
Visiting Us
About MSK CME
Contact
Help

ATTENDEE & FACULTY RESOURCES

Course Resources (My CME)
Claim CME Credit for a Live Course
Claim CME Credit for a RSS (MSK employees only)
MSK CME Disclosure Form
MSK CME Faculty Forms

STAY CONNECTED WITH US

Follow MSK CME on Twitter
Like MSK CME on Facebook
Join MSK CME on LinkedIn
Subscribe to MSK CME Course Announcements



MSK CME

mskcc.org | Legal Disclaimer | Privacy Practices | Public Notices
© 2023 Memorial Sloan Kettering Cancer Center